What You Should Know:
- Public health agencies across the US are at a crossroads, finds the Reimagining Public Health Survey produced by Ernst & Young LLP (EY US).
- This survey of 301 public health officials found that while slightly more than one in two (52%) are optimistic about what data can achieve for their communities, the rate of digital transformation remains uneven, and organizations face significant barriers to change.
Key Public Health Obstacles Post Covid-19
Public
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
RefleXion Medical Raises $125M for Biology-Guided Radiotherapy
What You Should Know:
- RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (BgRT) for all stages of cancer, today announced the closing of a $125M debt facility, of which $55M is available immediately to repay the company’s existing $50M of debt.
- The remaining $70M of the new facility will be made available upon reaching certain regulatory and commercial milestones. The funds will support the continued commercialization of the RefleXion X1
Read More
COTA Appoints Noel Alaka as VP of Life Sciences
What You Should Know:
Today, oncology real-world data analytics company COTA announced the appointment of Noel Alaka as Vice President of Life Sciences.
As VP of Life Sciences, Alaka will be responsible for helping grow and build partnerships with leading life sciences companies that are looking to adopt real-world data and real-world evidence to help accelerate innovation in treatments for patients facing cancer.
Noel Alaka Bio/Background
A benchtop
Read More
How Can Biopharma Companies Sustain Growth & Innovation?
What You Should Know:
- The traditional approach to fostering biopharma growth is no longer sustainable, according to Accenture research and analysis. The new research reveals perspectives on the life sciences industry based on an extensive analysis of over 300 M&A deals made by the top 30 biopharma companies between 2010–2021.
- The analysis reveals multiple factors are eroding the sustainability of an inorganic growth strategy, such as rising costs of M&A,
Read More
Care Access Acquires IBPClin to Expand Decentralized Clinical Trial Capabilities to Latin America
What You Should Know:
- Today, Care Access announced the acquisition of IBPClin, a leading clinical trial center in Rio de Janeiro. As a result, Care Access will bring its innovative approach to decentralized clinical research to Latin America.
- The acquisition demonstrates progress toward building diverse representation in clinical research and is a strategic first step following Reify Health’s $220 million investment
Read More
Merck Digital Sciences Studio Launches to Support Biomedical Startups
What You Should Know:
- Merck, today announced the launch of the Merck Digital Sciences Studio (MDSS) to enable the generation of innovative technologies for drug discovery and development.
- MDSS will support early-stage biomedical startups with direct investment, access to powerful Azure Cloud computing and opportunities to pilot their technologies in collaboration with discovery and clinical scientists at Merck.
MDSS Accelerator Program Focus
The MDSS is a collaboration between
Read More
Reimagining The Future of Pharmacovigilance (PV): Regulations, Tech, Public Perceptions
Monitoring the safe and effective use of medicines has now been an essential part of public health policy for several decades. New advances in technology (e.g., ICH E2B for the electronic exchange of case reports) over the past 20 years coupled with progressive legislation have been a catalyst for an explosion in safety data over this period.
Since the World Health Organization (WHO) declared the Covid-19 pandemic in March 2020, the rate of reporting of safety data has been unprecedented
Read More
Medidata Launches New Clinical Operations Technologies
What You Should Know:
- Today, Medidata, a Dassault Systèmes company, is announcing technology enhancements that address key issues in clinical trial management and oversight.
- These enhancements are to Medidata Detect and Rave CTMS (Clinical Trial Management System), which will improve both data oversight and reporting for sponsors and contract research organizations (CROs) in two meaningful ways: how they comprehensively monitor their trial data, and how they
Read More
Walgreens Launches New Clinical Trial Business to Address Access & Diversity
What You Should Know:
- Walgreens today announced the launch of its clinical trial business to redefine the patient experience and increase access and retention in sponsor-led drug development research.
- Walgreens flexible clinical trial model combines the company’s vast foundation of patient insights, partner-enabled health and technology capabilities and in-person and virtual care options to break through barriers to engaging broader and more diverse communities.
Patient Recruitment
Read More
BrightInsight Launches Digital Disease Management Solution for Biopharma
What You Should Know:
- BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions launches its Disease Management Solution.
- This configurable suite of digital applications includes a Patient App, Analytics Dashboards and Healthcare Provider Interfaces. The Disease Management Solution, built on the compliant BrightInsight® Platform on Google Cloud, meets biopharma and medtech customers’ core needs out-of-the-box to support
Read More
